Project Grant F32DA060685
Award Date
9/21/24
Completion Date
4/30/25
Dollars Obligated
$220K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Pullman, WA 99164, USA
Similar Awards
This Project Grant award, valued at $1,383,618.00, was issued by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant aims to investigate the role of microglia, a type of immune cell in the brain, in mediating the adverse effects of adolescent cannabis use on the maturation of the prefrontal cortex and cognitive function. The key objectives are to: 1) identify the molecular and morphological changes in microglia induced by...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $668,110 to Washington State University to refine and assess the feasibility and acceptability of a technology-based intervention for college students. The intervention aims to increase young adults' knowledge of cannabis products, laws, and associated risks, in order to reduce cannabis misuse among college students. The study will involve focus...
This Project Grant award of $285,641 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to investigate the impacts of developmental exposure to cannabinoids, including THC and CBD, on neuroinflammation and persistent behavioral deficits. The University of Mississippi, the award recipient, will leverage its expertise in cannabinoid research and utilize zebrafish models to: 1) assess morphological and behavioral...
This $229,500 federal Project Grant award, sponsored by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund research to investigate the mood, cognitive, and metabolic consequences of chronic vaporized cannabis exposure in mouse models of menopause. The key objectives are to: 1) establish the pharmacokinetics of vaporized cannabis in young adult and aged female mice with different endocrine status, 2) assess the effects of...
This $233,250 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support research at The Washington University in St. Louis to examine the relationship between early cannabis use and later opioid use disorder. The key objectives are to: 1) Estimate the association between early cannabis use and various aspects of opioid involvement, including initial subjective responses and opioid use disorder symptom severity, and whether...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $189,540 to the University of Pittsburgh to conduct a 5-year research study on the effects of schizophrenia and cannabis use on cannabinoid CB1 receptor expression and signaling in the dorsolateral prefrontal cortex. The study aims to characterize the independent and combined impacts of schizophrenia and THC exposure on terminal type-specific CB1...
The federal Project Grant award F32DA060612, totaling $360,100.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research on the socio-structural determinants of cannabis and derived psychoactive cannabis product use and consequences among young adults. This work aims to expand scientific understanding of cannabis use patterns and consequences as cannabis legalization for recreational use has...
This Project Grant award of $126,442 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to investigate the effects of delta-9-tetrahydrocannabinol (THC) exposure during brain development in a ferret model. The key objectives are to determine the impact of prenatal THC exposure on the expression and function of cannabinoid type-1 receptors (CB1Rs) in the primary visual cortex, and how these changes affect...
This $177,110 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research into the impact of cannabis legalization and commercialization on substance use and mental health outcomes among individuals with psychosis. The awardee, the Cambridge Public Health Commission (doing business as the Cambridge Health Alliance), will utilize quasi-experimental difference-in-difference methods to analyze...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the neural and psychiatric consequences of cannabis use in adolescents with depression. The $2,118,992 award will fund a 5-year study (9/30/2024 - 5/31/2029) to be conducted by the University of Miami. The research seeks to understand how depression and cannabis use in adolescents may have an additive effect on alterations in reward...